Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Your Environment. Your Health.

Publication Detail

Title: Cisplatin-DNA adduct repair of transcribed genes is controlled by two circadian programs in mouse tissues.

Authors: Yang, Yanyan; Adebali, Ogun; Wu, Gang; Selby, Christopher P; Chiou, Yi-Ying; Rashid, Naim; Hu, Jinchuan; Hogenesch, John B; Sancar, Aziz

Published In Proc Natl Acad Sci U S A, (2018 05 22)

Abstract: Cisplatin is a major cancer chemotherapeutic drug. It kills cancer cells by damaging their DNA, mainly in the form of Pt-d(GpG) diadducts. However, it also has serious side effects, including nephrotoxicity and hepatotoxicity that limit its usefulness. Chronotherapy is taking circadian time into account during therapy to improve the therapeutic index, by improving efficacy and/or limiting toxicity. To this end, we tested the impact of clock time on excision repair of cisplatin-induced DNA damage at single-nucleotide resolution across the genome in mouse kidney and liver. We found that genome repair is controlled by two circadian programs. Repair of the transcribed strand (TS) of active, circadian-controlled genes is dictated by each gene's phase of transcription, which falls across the circadian cycle with prominent peaks at dawn and dusk. In contrast, repair of the nontranscribed strand (NTS) of all genes, repair of intergenic DNA, and global repair overall peaks at Zeitgeber time ZT08, as basal repair capacity, which is controlled by the circadian clock, peaks at this circadian time. Consequently, the TS and NTS of many genes are repaired out of phase. As most cancers are thought to have defective circadian rhythms, these results suggest that future research on timed dosage of cisplatin could potentially reduce damage to healthy tissue and improve its therapeutic index.

PubMed ID: 29735688 Exiting the NIEHS site

MeSH Terms: Animals; Antineoplastic Agents/pharmacology*; Circadian Rhythm/drug effects; Circadian Rhythm/genetics*; Cisplatin/pharmacology*; DNA Adducts/pharmacology*; DNA Damage*; DNA Repair*; Female; Genome, Human*; Humans; Mice; Mice, Inbred C57BL; Neoplasms/drug therapy; Neoplasms/genetics*; Transcription, Genetic/drug effects

to Top